Disintegration testing determines whether tablets or capsules disintegrate within a defined period of time when placed in a liquid medium. Compliant design according to current Pharmacopeia (USP <701>, USP <2040>, Ph. Eur. 2.9.1) and robust Swiss quality components provide a reproducible and standardized method of ensuring that complete disintegration has taken place. Innovative automated end-point detection and recording of individual disintegration times per sample allow unattended testing without manual observation by operators.